Tonix Pharmaceuticals Holding Corp
Change company Symbol lookup
Select an option...
TNXP Tonix Pharmaceuticals Holding Corp
PEP PepsiCo Inc
PVTL Pivotal Software Inc
AIPT Precision Therapeutics Inc
SPN Superior Energy Services Inc
NOV National Oilwell Varco Inc
SCS Steelcase Inc
PRTK Paratek Pharmaceuticals Inc
ASPU Aspen Group Inc
AFBA Allied First Bancorp Inc
Go

*Nasdaq FSI: *Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements

Health Care : Biotechnology | Small Cap ValueCompany profile

Tonix Pharmaceuticals Holding Corp. is a clinical-stage pharmaceutical company. The Company's drug development programs are directed toward disorders affecting the central nervous system (CNS), and include fibromyalgia (FM), and post-traumatic stress disorder (PTSD). It is focused on developing a portfolio of product candidates, including one product candidate in clinical development for registration in two indications. TNX-102 SL (cyclobenzaprine hydrochloric acid (HCl) sublingual tablets), is a disintegrating tablet containing cyclobenzaprine (CBP) for sublingual administration. The Company has completed Phase IIb BESTFIT trial of TNX-102 SL for fibromyalgia. It is being evaluated in the Phase III AFFIRM study for the treatment of fibromyalgia. The Company is also conducting AtEase trial, which is a Phase II clinical trial of TNX-102 SL in military-related PTSD. It also has a pipeline of other product candidates, including TNX-301, a fixed dose combination drug product (CDP).

Price
Delayed
$2.81
Day's Change
0.0927 (3.41%)
Bid
--
Ask
--
B/A Size
--
Day's High
2.90
Day's Low
2.80
Volume
(Light)

Today's volume of 207,443 shares is on pace to be much lighter than TNXP's 10-day average volume of 3,656,744 shares.

207,443
  • Prev Close
    2.72
  • Today's Open
    2.90
  • Day's Range
    2.80-2.90
  • Avg Vol (10-day)
    3.7M
  • Last (time)
    11:15a ET 12/11/18
  • Last (size)
    5.0K
  • 52-Wk Range
    2.64 - 51.10
    LowHigh
  • (06/07/18 - 12/10/18)
    6.54%
  • 150.8%
  • Market Cap
    39.9M
  • Shares Outstanding
    14.2M
  • -28.85
  • --
  • No dividend
  • Ex-dividend
    No dividend
  • 1.4
  • 11.89
  • (% of float 11/15/18)
    9.87

Latest News

November 29, 2018
7:00 am ET
Globe Newswire
November 27, 2018
7:00 am ET
Globe Newswire
November 21, 2018
7:35 am ET
Globe Newswire
November 09, 2018
7:30 am ET
Globe Newswire
November 07, 2018
7:10 am ET
Globe Newswire
November 06, 2018
7:01 am ET
Globe Newswire
November 01, 2018
7:01 am ET
Globe Newswire
October 31, 2018
7:00 am ET
Globe Newswire
October 29, 2018
7:00 am ET
Globe Newswire
October 23, 2018
7:00 am ET
Globe Newswire
September 26, 2018
1:30 pm ET
Globe Newswire
September 20, 2018
7:00 am ET
Globe Newswire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2018 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2018. All rights reserved.